[1] Probert F, Ruizrodado Ⅴ, Zhang X, et al. Urinary excretion and metabolism of miglustat and valproate in patients with Niemann-Pick type C1 disease: One-and two-dimensional solution-state (1)HNMR studies[J]. J Pharma Biomed Analy, 2015, 117:276-288.
[2] Patterson MC, Walkley SU. Niemann-Pick disease, type C and Roscoe Brady[J]. Mol Genet Metab, 2017, 120(1-2):34-37.
[3] Vanier MT. Niemann-Pick diseases[J]. Handb Clin Neurol, 2013, 113: 1717-1721.
[4] Lyseng-Williamson KA. Miglustat: a review of its use in Niemann-Pick disease type C[J]. Drugs, 2014, 74 (1): 61-74.
[5] Ebner L, Gl?ser A, Bruer A, et al. Evaluation of two liver treatment strategies in a mouse model of Niemann-Pick-Disease type C1[J]. Int J Mol Sci, 2018, 19(4):972.
[6] Ebrahimifakhari D, Wahlster L, Bartz F, et al. Reduction of TMEM97 increases NPC1 protein levels and restores cholesterol trafficking in Niemann-pick type C1 disease cells[J]. Hum Mol Genet, 2016, 25(16):3588-3599.
[7] Beltroy EP, Richardson JA, Horton JD, et al. Cholesterol accumulation and liver cell death in mice with Niemann-Pick type C disease[J]. Hepatology, 2005, 42 (4): 886-893.
[8] Rimkunas VM, Graham MJ, Crooke RM, et al. In vivo antisense oligonucleotide reduction of NPC1 expression as a novel mouse model for Niemann Pick type C-associated liver disease[J]. Hepatology, 2008, 47 (5): 1504-1512.
[9] Rimkunas VM, Graham MJ, Crooke RM, et al. TNF-{alpha} plays a role in hepatocyte apoptosis in Niemann-Pick type C liver disease[J]. J Lipid Res, 2009, 50 (2): 327-333.
[10] Li X, Saha P, Li J, et al. Clues to the mechanism of cholesterol transfer from the structure of NPC1 middle lumenal domain bound to NPC2[J]. Proc Natl Acad Sci USA, 2016, 113(36):10079-10084.
[11] Cologna SM, Cluzeau CVM, Yanjanin NM, et al. Human and mouse neuroinflammation markers in Niemann-Pick disease type C1[J]. J Inherit Metab Dis, 2014, 37(1):83-92.
[12] Ren LP,Du GJ, Cui XP, et al. Study on protective effect of taraxactherba on alcohol-induced liver injury[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2011, 17(11): 179-181.(in Chinese)
任丽平, 杜钢军, 崔新萍,等. 蒲公英对酒精性肝损伤的影响[J]. 中国实验方剂学杂志, 2011, 17(11): 179-181.
[13] Sun Y, Meng XW, Chi BR, et al. New improvements in the research of hepatic injury induced by alchilic[J]. Jilin Medical Journal, 2006, 27(3): 230-231.(in Chinese)
孙艳, 孟祥伟, 迟宝荣,等. 酒精性肝病发病机制的研究进展[J]. 吉林医学, 2006, 27(3): 230-231.
[14] Gong X, Qian H, Zhou X, et al. Structural insights into the Niemann-Pick C1 (NPC1)-mediated cholesterol transfer and ebola infection[J]. Cell, 2016, 165 (6): 1467-1478.
[15] Castellano BM, Thelen AM, Moldavski O, et al. Lysosomal cholesterol activates mTORC1 via an SLC38A9-NiemannPick C1 signaling complex[J]. Science, 2017, 355 (6331): 1306-1311.
[16] Mac ías-Vidal J, Guerrero-Hernández M, Estanyol JM, et al. Identification of lysosomal Npc1-binding proteins: Cathepsin D activity is regulated by NPC1[J]. Proteomics, 2016, 16(1):150-158.
[17] Vanier MT. Complex lipid trafficking in Niemann-Pick disease type C[J]. J Inherit Metab Dis, 2015, 38(1):187-199.
[18] Baudry M, Yao Y, Simmons D, et al. Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia[J]. Exp Neurol, 2003, 184 (2): 887-903.
[19] Meyer A, Wree A, Günther R, et al. Increased regenerative capacity of the olfactory epithelium in Niemann-Pick disease type C1[J]. Int J Mol Sci, 2017, 18(4):777.
[20] Voikar V, Rauvala H, Ikonen E. Cognitive deficit and development of motor impairment in a mouse model of Niemann-Pick type C disease[J]. Behav Brain Res, 2002, 132 (1): 1-10.
[21] Yan X, Yang F, Lukas J, et al. Hyperactive glial cells contribute to axonal pathologies in the spinal cord of Npc1 mutant mice[J]. Glia, 2014, 62(7):1024-1040.
|